Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of antibodies to SARS-CoV-2 is particularly high in patient population with ocular surface diseases

Shengjie Li, Yichao Qiu, Li Tang, Zhujian Wang, Wenjun Cao, Xinghuai Sun
doi: https://doi.org/10.1101/2020.09.22.20198465
Shengjie Li
1Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
2Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yichao Qiu
1Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Tang
1Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhujian Wang
1Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenjun Cao
1Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
2Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wgkjyk@aliyun.com
Xinghuai Sun
2Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Coronavirus disease 2019 (COVID-19), a novel respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019. It is vitally important to perform a seroprevalence study to estimate the percentage of people with SARS-CoV-2 antibodies in the patient population with ocular surface diseases. IgG and IgM antibodies against the SARS-CoV-2 spike protein and nucleoprotein were measured using a commercially available magnetic chemiluminescence enzyme immunoassay kit. Throat swabs were tested for SARS-CoV-2 RNA in a designated virology laboratory. A total of 6, 414 individuals were enrolled. All participants throat swabs were RT-PCR-negative for SARS-CoV-2. Seroprevalence in the patient population was 0.31%. And the seroprevalevce in ocular surface diseases, no-ocular surface diseases and no-ocular diseases are 1.82% (6/330), 0.22% (10/4614) and 0.27% (4/1470) respectively.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

NA

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Medical Ethics Committees of Eye and ENT Hospital of Fudan University approved this study

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The raw data supporting the conclusions of this article will be made available by the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 19, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seroprevalence of antibodies to SARS-CoV-2 is particularly high in patient population with ocular surface diseases
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seroprevalence of antibodies to SARS-CoV-2 is particularly high in patient population with ocular surface diseases
Shengjie Li, Yichao Qiu, Li Tang, Zhujian Wang, Wenjun Cao, Xinghuai Sun
medRxiv 2020.09.22.20198465; doi: https://doi.org/10.1101/2020.09.22.20198465
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Seroprevalence of antibodies to SARS-CoV-2 is particularly high in patient population with ocular surface diseases
Shengjie Li, Yichao Qiu, Li Tang, Zhujian Wang, Wenjun Cao, Xinghuai Sun
medRxiv 2020.09.22.20198465; doi: https://doi.org/10.1101/2020.09.22.20198465

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Ophthalmology
  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8534)
  • Forensic Medicine (4)
  • Gastroenterology (381)
  • Genetic and Genomic Medicine (1739)
  • Geriatric Medicine (167)
  • Health Economics (370)
  • Health Informatics (1234)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (369)
  • Infectious Diseases (except HIV/AIDS) (10271)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1666)
  • Nursing (97)
  • Nutrition (247)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (262)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (110)
  • Palliative Medicine (40)
  • Pathology (249)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (205)
  • Psychiatry and Clinical Psychology (1757)
  • Public and Global Health (3825)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (317)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (164)
  • Sports Medicine (156)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)